From: Photoacoustic and high-frequency ultrasound imaging of systemic sclerosis patients
Early SSc (n = 5) | SSc (n = 12) | PR (n = 5) | HV (n = 9) | |
---|---|---|---|---|
Age in years (median, IQR) | 40 (32–58) | 59 (46–62) | 29 (25–44) | 34 (26–52) |
Female (%) | 80% | 42% | 60% | 33% |
Disease duration in months (median, IQR) | 12 (5–29) | 88 (33–108) | – | – |
mRSS (median, IQR) | – | 5 (3–10) | – | – |
ILD (%) | – | 58% | – | – |
Co-medication use (%) | ||||
Calcium antagonist | 40% | 42% | – | – |
Angiotensin 2 inhibitor | 0% | 17% | – | – |
Endothelin antagonist | 0% | 8% | – | – |
None | 60% | 33% | 100% | 100% |